Emerging Insights into Skincare Highlight the Role of the Immune System

This new perspective could reshape the design and testing of skincare products and the claims that regulatory bodies allow. Skin cells can identify germs, pollutants, and injury, releasing signaling proteins that help manage inflammation and healing processes. Additionally, immune cells play a role in detecting harmful substances, clearing damaged cells, and preventing prolonged immune responses.

While inflammation is crucial during skin injury or infection, excessive or unregulated responses can lead to irritation and disease. Research into conditions like acne indicates that inflammation may be triggered even before physical symptoms appear; factors such as oil production and bacteria interact with the immune system to influence acne's development. Similarly, rosacea involves inflammation and changes to skin nerves and blood vessels, while atopic dermatitis and psoriasis showcase varying immune responses affecting the skin.

Researchers are also studying the concept of "inflammaging," referring to low-level chronic inflammation linked to aging. This process could hinder skin repair and alter collagen and other supportive skin structures. Investigations are ongoing into whether skincare could mitigate harmful inflammation and protect against UV-related aging, though current evidence on cosmetics' effectiveness in slowing inflammaging remains limited.

Another focus of research is the skin microbiome, which comprises various microorganisms living on the skin. These communities differ among individuals and skin areas, interacting with immune cells, aiding in pathogen defense, and affecting inflammation and barrier functions. While there is no clear definition of a healthy microbiome, skincare products now often claim to "support" or "protect" it using probiotics, prebiotics, or postbiotics. Though some research offers promising findings, variations in products and studies highlight the need for more substantial clinical trials.

Future research could change product testing methods, moving beyond hydration and visible wrinkles to include biological measures like cytokines—proteins used by cells for immune signaling. Although some inflammatory cytokines can be measured in skin samples, establishing a direct link between lab measurements and tangible benefits for users remains essential.

Emerging technologies, such as nanotechnology, may offer novel delivery methods for cosmetic ingredients. Researchers are exploring whether nanoparticles can effectively convey ingredients while modulating immune responses, though this research is still in the experimental phase.

Claims about influencing immune function might challenge the distinction between cosmetics and medicines. In the UK, the Medicines and Healthcare products Regulatory Agency assesses product claims and intended uses to determine the appropriate regulatory classification. Products aimed at improving skin appearance may be classified as cosmetics, while those claiming to treat diseases or alter immune functions might fall under stricter medicinal regulations.

As skin immunity research progresses, it could significantly impact cosmetic science, providing fresh perspectives on skin health. However, consumers and regulators must remain vigilant, differentiating between products that deliver genuine benefits and those that leverage emerging scientific terminology without substantial evidence.